Trivitron Healthcare Profile
Key Indicators
- Authorised Capital ₹ 7.10 Cr
- Paid Up Capital ₹ 2.89 Cr
- Company Age 26 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 345.84 Cr
- Satisfied Charges ₹ 644.53 Cr
- Revenue Growth -50.17%
- Profit Growth -130.38%
- Ebitda -144.44%
- Net Worth -7.06%
- Total Assets -3.12%
About Trivitron Healthcare
Trivitron Healthcare Private Limited (THPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 May 1998 and has a history of 26 years and eight months. Its registered office is in Chennai 600018, Tamil Nadu, India.
The Corporate was formerly known as Trivitron Diagnostics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.10 Cr and a paid-up capital of Rs 2.89 Cr.
The company currently has active open charges totaling ₹345.84 Cr. The company has closed loans amounting to ₹644.53 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Trivitron Healthcare Private Limited India is Seshadri Vasudevan as COMPANY SECRETARY. Subha Velu, Gomathy Kulandaivelu, Athmanathan Ganesan, and Three other members serve as directors at the Company.
Company Details
- Location
Chennai 600018, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110TN1998PTC040515
- Company No.
040515
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 1998
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Trivitron Healthcare Private Limited offer?
Trivitron Healthcare Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Alcohol Solvents, Medical Laboratory Instruments, Pathology Lab Equipments, Diagnostic Medical Imaging Equipment, X Ray Machine, Doppler Machine, Surgical & ICU Equipments, Operation Theater Equipments, Diagnostic Imaging Accessories.
Who are the key members and board of directors at Trivitron Healthcare?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gomathy Kulandaivelu  | Managing Director | 18-May-1998 | Current |
| Seshadri Vasudevan | Company Secretary | 03-Dec-2020 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandra Ganjoo | Director | 20-Jan-2016 | Current |
| Subha Velu | Director | 18-May-1998 | Current |
| Athmanathan Ganesan | Director | 03-Dec-2013 | Current |
| Satyaki Banerjee | Additional Director | 23-Dec-2022 | Current |
| Nilesh Devare | Additional Director | 03-Jul-2024 | Current |
Financial Performance of Trivitron Healthcare.
Trivitron Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 50.17% decrease. The company also saw a substantial fall in profitability, with a 130.38% decrease in profit. The company's net worth dipped by a decrease of 7.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trivitron Healthcare?
In 2023, Trivitron Healthcare had a promoter holding of 60.26% and a public holding of 39.74%. The company had 5 Subsidiaries and 3 Joint Ventures. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neuberg Abha Laboratory Private LimitedGomathy Kulandaivelu and Athmanathan Ganesan are mutual person
Magnum Imaging & Diagnostics Private LimitedSubha Velu and Athmanathan Ganesan are mutual person
Stakeboat Ventures LlpGomathy Kulandaivelu and Athmanathan Ganesan are mutual person
- Stakeboat Capital Llp
Athmanathan Ganesan is a mutual person
Labsystems Diagnostics India Private LimitedSubha Velu is a mutual person
- Hexel Technologies Private Limited
Subha Velu and Chandra Ganjoo are mutual person
Charges (Loans)
₹345.84 Cr
₹644.53 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 195.01 Cr
- Others : 75.45 Cr
- Axis Bank Limited : 74.10 Cr
- Siemens Financial Services Private Limited : 1.28 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2024 | Others | ₹10.00 Cr | Open |
| 28 Feb 2023 | Hdfc Bank Limited | ₹4.02 M | Open |
| 29 Nov 2022 | Others | ₹20.00 Cr | Open |
| 30 Sep 2022 | Others | ₹9.00 M | Open |
| 30 May 2022 | Others | ₹42.00 Cr | Open |
How Many Employees Work at Trivitron Healthcare?
Trivitron Healthcare has a workforce of 513 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trivitron Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trivitron Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
